Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
N$g(a)-2-(4-NITROPHENYLSULFONYL)ETHOXYCARBONYL-AMINO ACID FLUORIDES AND PROCESS FOR THE PREPARATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2001/051505
Kind Code:
A1
Abstract:
There are provided by the present invention new N$g(a)-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acid fluorides as described in the general formula (I) wherein R¿1? represents hydrogen and R¿2? may represent hydrogen, isopropyl, 2-methylpropyl, tert-butoxymethyl, benzyl, 2-(tert-butoxycarbonyl)ethyl, 4-(tert-butoxycarbamido)butyl or 4-tert-butoxybenzyl, and process for the preparation thereof. By using the amino acid fluorides according to the present invention, a certain desired peptide may be easily synthesized without activation step.

Inventors:
KIM HACK-JOO (KR)
CHWEH WEONU (KR)
KIM YOUNG-CHEOL (KR)
Application Number:
PCT/KR1999/000810
Publication Date:
July 19, 2001
Filing Date:
December 24, 1999
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HYUNDAI PHARMACEUTICAL IND CO (KR)
KIM HACK JOO (KR)
CHWEH WEONU (KR)
KIM YOUNG CHEOL (KR)
International Classes:
C07C317/18; C07K1/06; C07K1/08; (IPC1-7): C07K5/00
Domestic Patent References:
WO1996025394A11996-08-22
WO1998017638A11998-04-30
Other References:
VLADIMIR V. SAMUKOV ET AL.: "2-(4-nitrophenyl) sulfornylethoxycarbonyl (Nsc) group as a base-labile alpha-amino protection for solid phase peptide symthesis", TETRAHEDRON LETTERS, vol. 35, no. 42, 1994, pages 7821 - 7824
Attorney, Agent or Firm:
Park, Sa-ryong (Chongho Bldg. 823-5, Yeoksam 1-dong Kangnam-gu Seoul 135-081, KR)
Download PDF:
Claims:
CLAIMS
1. A Na2 (4nitrophenylsulfonyl) ethoxycarbonylamino acid fluoride derivative represented by the following formula (I) : in which R, represents hydrogen ; and R2 represents hydrogen, isopropyl, 2methypropyl, tertbutoxymethyl, benzyl, 2 (tert butoxycarbonyl) ethyl, 4 (tertbutoxycarbamido) butyl or 4tertbutoxybenzyl.
2. A process for preparing Na2 (4nitrophenylsulfonyl) ethoxycarbonylamino acid fluoride derivatives represented by the following formula (I), which comprises fluorinating a Nscamino acid of formula (II) in an organic solvent : Na NscNR1CHR2COOH NQNscNRlCHR2COF (II) (I) wherein R, and R2 are defined as in claim 1.
3. The process as defined in claim 2, characterized in that the organic solvent is dichloromethane or tetrahydrofuran and an agent for fluorination is cyanuric fluoride and pyridine.
4. A process for synthesis of peptides in a solid phase by using a Na2 (4 nitrophenylsulfonyl) ethoxycarbonylamino acid fluoride derivative represented by the following formula (I) without activation step : wherein R, and R2 are defined as in claim 1.
Description:
Na-2- (4-NITROPHENYLSULFONYL) ETHOXYCARBONYL-AMINO ACID FLUORIDES AND PROCESS FOR THE PREPARATION THEREOF TECHNICAL FIELD The present invention provides a process for preparing a protected amino acid derivative for solid phase peptide synthesis, i. e. a Na-protected amino acid fluoride obtained starting from a Na-2- (4-nitrophenysulfonyl) ethoxycarbonyl-amino acid (Na- Nsc-amino acid) by substituting a carboxyl group at the terminal of various Na- protected amino acids with fluoride in solid phase peptide synthesis. The compound thus produced is a Na-2- (4-nitrophenysulfonyl) ethoxycarbonyl-amino acid (Na-Nsc- amino cid) fluoride having the following formula (I) : in which R, represents hydrogen ; and R2 represents hydrogen, isopropyl, 2-methypropyl, tert-butoxymethyl, benzyl, 2- (tert- butoxycarbonyl) ethyl, 4- (tert-butoxycarbamido) butyl or 4-tert-butoxybenzyl.

BACKGROUND ART Solid phase peptide synthesis is widely employed for the preparation of biologically active peptides, which are used in medical and biological research and also as active substance in pharmacy, veterinary and diagnostics. The essence of solid phase peptide synthesis can be outlined as a stepwise elongation of a peptide chain by means of repeated cycles of chemical reactions, beginning from the first C-terminal

amino acid attached to an insoluble carrier. During the course of the synthesis target products of all reactions remain bound to the carrier, whereas excessive reactants and side-products are removed by filtration and washing of the carrier.

In order to perform the solid phase synthesis of a peptide, the first amino acid (C-terminal of the target amino acid sequence) with the protected a-amino group is linked covalently to an insoluble polymeric carrier through the free carboxyl group by ester or amide bond formation. Then, Na-protective group is selectively cleaved from thus obtained Na-protected aminoacyl-polymer to form the aminoacyl-polymer with the free a-amino group. This polymer is further acylated with the next Na-protected amino acid to obtain Na-protected dipeptide-polymer. Such synthetic cycles, which consist of Na-protection cleavage and of subsequent acylation of free amino group with following Na-protected amino acid, are repeated until the assembly of target amino acid sequence is completed.

In practical solid phase synthesis, since a large molar excessive amount (2 to 10-fold) of acylating agent is usually employed to assure a complete conversion, all reactive groups in side chains of the amino acids, such as amino, carboxyl, hydroxyl, thiol, guanidino groups, should be blocked with appropriate protective groups. The protective groups for this purpose must be selected carefully to provide reliable and permanent protection of the side chains under conditions of peptidyl-polymer acylations and during the cleavage of temporary Na-protection. On the other hand, these side- chain protective groups must provide the opportunity to deprotect the synthesized peptide in one or two stages quantitatively and without damage of its structure. In most cases, the peptidyl-polymer linkage also should be cleaved simultaneously. It is evident that the structure and the chemical properties of permanent protective groups for side-chains of amino acids are determined not only by the nature of reactive function to be protected but in a great extent by the structure and the chemical properties of the employed temporary Na-protective group. Therefore, temporary Na-protection is the

key element of the whole strategy of solid phase peptide synthesis.

For the purpose of solid phase peptide synthesis, Na-tert-butoxycarbonyl amino acids (Boc-amino acids) are well known and widely used (R. B. Merrifield, Biochemistry, 1964, V. 3, p. 1385). Tert-butoxycarbonyl (Boc) group can be removed by the action of acidic reagents of medium strength, such as, for example, trifluoroacetic acid and its solutions in chlorinated hydrocarbons, solutions of hydrogen chloride in organic solvents, boron trifluoride/diethyl ether complex and some other acids, to form isobutylene and carbon dioxide.

Together with temporary Na-Boc-protection, a protective group is employed for permanent blocking of side chains, which is stable during Na-Boc cleavage but can be cleaved by a stronger acidic reagent with the simultaneous fission of peptidyl- polymer bond. The known reagents, which can be used for this purpose include liquid hydrogen fluoride, trifuoromethanesulfonic acid and their mixtures with anisole, thioanisole or dimethylsulfide. The main drawback of the synthetic strategy with the use of temporary Na-Boc-protection is the application of an acid hydrolysis for the cleavage of both temporary and permanent protective groups, which cannot provide a complete stability of permanent protection. As the length of synthesized peptide grows, a permanent protective group experiences the repeated action of acidic reagents during a Boc cleavage step, which can result in a partial loss of these groups and the accumulation of by-products. Otherwise, the final treatment of peptidyl-polymer complex with a superacidic reagent may cause a partial destruction of the target peptide.

Due to an extremely hazardous property of superacids, it should also be noticed that superacids must be handled with a special equipment and an appropriate safety measures.

To avoid the use of superacidic reagents for deprotection of the final peptides, it is regarded that several acid-sensitive groups recently proposed as a temporary Na- protective group are suitable to a permanent side-chain protection in the so-called tert-

butyl type, which can be cleaved by acidic reagents of medium strength. As a typical example of such Na-protective groups, 1- (3, 5-di-tert-butylphenyl)-1- methylethoxycarbonyl (t-Bumeoc) group has been disclosed in the literature (Collect.

Czech. Chem. Commun., 1992, V. 57, p. 1707). Na-tert-Bumeoc group can be cleaved by 1% trifluoroacetic acid dissolved in dichloromethane and used together with a permanent protective group in the form of t-butyl cleavable by neat trifluoroacetic acid or its concentrated solutions. In this case, although the use of superacids can be avoided, a general principle of differential acid hydrolysis still remains unchanged.

Another approach to accomplish the strategy of solid phase peptide synthesis has been made R. B. Merrifield in Science, 1986, V. 232, p. 341. This approach, called"orthogonality principle", is based on the assumption that temporary and permanent protective groups can be removed by totally distinct reagents according to totally different chemical mechanisms, so that temporary Na-protection can be cleaved with an absolute selectivity to provide the complete preservation of permanent protection, and vice versa. At the present time, the"orthogonality principle"has been commonly accepted as a guideline for the development of efficient strategies of solid phase peptide synthesis.

As an example of implementation of the"orthogonality principle"the use of Na-dithiasuccinylamino acid (Dts-amino acid) in solid phase synthesis has been described in Int. J. Peptide and Protein Res., 1987, V. 30. p. 740. Na-dithiasuccinyl (Dts) protective group is quite resistant to acidic reagents of medium strength and is cleaved smoothly by thiol reagents in neutral media with the liberation of amino group and formation of carbon thiooxide. Application of Dts-amino acid in practical synthesis is still limited due to the lack of effective methods for their preparation.

The most widely known and employed strategy of solid phase synthesis according to the"orthogonality principle"is based on the use of Na-9- fluorenylmethoxycarbonylamino acids (Fmoc-amino acids), as described by C. D.

Chang and J. Meienhofer in Int. J. Peptide and Protein Res., 1975, V. 11, p. 246. Na- 9-fluorenylmethoxycarbonyl (Fmoc) group is resistant to acidic reagents and is cleaved according to the (3-elimination mechanism by organic bases in aprotic solvents, for example, by morpholine diethylamine, piperazine, or piperidine in dimethylformamide (DMF) or dichloromethane, amino group being liberated and dibenzofulvene being formed together with CO2. In solid phase synthesis the cleavage of Fmoc group is preferably performed by the treatment of Na-protected peptidyl-polymer with 20 to 50% piperidine solution in DMF during 10 to 30 minutes. Said conditions can allow to use a permanent acid-sensitive protection of t-butyl type together with temporary Na- Fmoc-protection, thus providing the"othogonality"of the synthetic strategy.

Na-Fmoc-amino acids have been widely used in automatic and semi-automatic synthesizer of all types, as well as in manual solid phase peptide synthesis. However, due to an extreme base sensitivity and instability in neutral aprotic solvents of Na- Fmoc-protective group the acylation conditions and further the purity of used solvents should be carefully controlled. Special care should be taken when Na-Fmoc-amino acids are used for the synthesis of peptides exceeding 30 residues in length. In addition, a relatively high production cost prevents the use of Fmoc-derivatives in a large scale peptide preparation.

For such reasons, it has still been required to develop the novel Na-protected amino acid derivatives useful for effective strategy of solid phase peptide synthesis.

To satisfy such requirement Na-2- (4-nitrophenylsulfonyl) ethoxycarbonyl-amino acids (Na-Nsc-amino acids) have been developed and WO 06/25394 relating to their preparation and their application to solid phase peptide synthesis has been registered as a patent in US, Europe, Japan, Australia and Korea, of which the right is owned by Hyundai Pharmaceutical Co., Ltd. as the applicant of the present application. The study relating to them has been continuously and extensively conducted, and as a result, WO 98/17638 relating to Na-Nsc-amino acids, which were not included in WO

96/25394, is in progress of patent examination procedure in several countries in the world.

In the above patents and numerous references, it has been identified that Nsc- amino acids used as the novel starting material in the present invention have a superior stability and efficiency in comparison to the prior Fmoc-amino acids, and therefore, in applying to the actual synthetic procedures can increase the stability and efficiency and provide a good yield to secure the economic advantage.

Numerous studies have continuously been made by other researchers to secure the superiority in solid phase peptide synthesis. According to this. an effort to make up for the problems involved in the synthesis of peptides using Fmoc-amino acids as mentioned above and to obtain the substances providing an equivalent effect and efficacy has been made and thus, the study about Fmoc-amino acid fluorides in order to solve the problem of impurities produced during activation step and a long process time in case of the synthesis using Fmoc-amino acids has been disclosed in several reports (Carpino, et al., Acc. Chem. Res. 1996, V29,-268-274). However, such study could never be commercialized due to the problem of stability of the materials. As one alternative, which can overcome the problem that in spite of the advantage of synthesis Fmoc-amino acid fluorides could not be commercialized due to their poor stability and storability, the present invention has been made.

Na-Nsc-amino acid fluorides used in the present invention are obtained from fluorination of Na-Nsc-amino acids and using the same the method for obtaining the desired peptides by a direct coupling of amino acids without any activation step, which is regarded as their unique advantage corresponding to Na-Nsc-amino acids in solid phase peptide synthesis, has been explored.

DETAILED DESCRIPTION OF INVENTION

The synthesis of numerous peptides using Na-Nsc-amino acids has been successfully progressed under general condensing conditions. Such synthetic method is disclosed, of course, in the above-mentioned patents together with its specific examples and further, the matters related to them are reported in numerous papers as the product of study. The matters of such study takes advantages of the stability and relatively increased hydrophilic property of Na-Nsc-amino acids to improve the major problem of the prior synthetic methods, which may be caused during the procedure for obtaining the desired synthesized product by cleaving Na-protected amino acid halides with water. Thus, since Na-Nsc-amino acids can be readily synthesized, and are cheap and economically useful, they are necessarily required for application to a peptide synthesis using a solid support.

The superior utility of Na-Nsc-amino acids are under commercialization so as to be readily used by many persons and further, an effort to design techniques for solid phase peptide synthesis comparable or superior to them are in progress. As a result of such a series of study, some cases showing the result of synthesis in a high efficiency but in a lower stability in comparison to Na-Nsc-amino acids have been reported. In conventional peptide synthesis, the reaction was conducted by addition of Na-Nsc- amino acids and activating agents. However, due to the presence of activating agents the products obtained after completion of the reaction may contain many impurities, which are required to separate by washing and removing. Such separation step is, of course, not difficult to practice, but requires the consumption of time and lowers the relative yield of the desired product.

The present invention provides a momentum for synthesis of peptides, which were technically difficult to practice, by adding fluorides to Na-Nsc-amino acids through an easy fluorination to obtain Na-Nsc-amino acid fluorides for increasing the utility of Na-Nsc-amino acids, and then directly applying Na-Nsc-amino acid fluorides thus obtained to the actual synthesis of peptides. In case of the synthesis using Na-

Nsc-amino acids to which fluorides are added, the synthetic reaction can be readily proceeded without addition of any activating agent and the reaction products are obtained in a high purity. Contrary to this, the reaction product obtained from the synthetic reaction practiced by simply adding activating agents to Na-Nsc-amino acids contains some impurities remained therein and therefore, are produced in a lower yield.

Of course, in case that the synthesis is practiced by adding activating agents, the reaction is more stably proceeded in comparison to the synthesis only using Na-Nsc- amino acid fluorides so that the peptide can be prepared in a large scale. However, due to one additional step for activation the synthesis may be regarded as being somewhat disadvantageous in view of the time required for synthesis.

According to the present invention, peptides having amino acids chain which were very difficult to synthesize according to the peptide synthesis using the well- known prior urethane-protected amino acid halides, particularly, Fmoc-amino acids or Fmoc-amino acid-halides, can be readily synthesized by applying Na-Nsc-amino acid halides, to show an increase in convenience and efficiency of peptide synthesis.

First, the method for synthesis of Na-Nsc-amino acid fluorides can be represented by the following reaction scheme : Scheme 1 fluorinating agent Na-Nsc-NRI-CHR2-COOH Na-Nsc-NR-CHR2-COF organic solvent In the above reaction scheme, R, represents hydrogen and R2 represents hydrogen, isopropyl, 2-methylpropyl, tert-butoxymethyl, benzyl, 2- (tert- butoxycarbonyl) ethyl, 4- (tert-butoxycarbamido) butyl or 4-tert-butoxybenzyl.

In order to synthesize the desired product according to the above reaction scheme, the relevant Nsc-amino acid is used as the starting material to which a fluorinating agent, for example, cyanuric fluoride (3. 0 eq.) and pyridine (1. 0 eq.), in an organic solvent, for example, dichloromethane (DCM) or tetrahydrofuran (THF) solvent is added to proceed the reaction. This fluorination reaction is completed within about 30 minutes at room temperature.

As the solvent, dichloromethane (DCM) can be generally used except for Nsc- Gly-OH, Nsc-Phe-OH and Nsc-Leu-OH, which have a slight solubility in dichloromethane (DCM) solvent. In addition, in order to avoid the aggregation of reactants during the reaction it is useful to dilute the solvent concentration from 0. 04 M to 0. 02M.

The completion of this reaction can be confirmed first by a thin layer chromatography (TLC) and then by a high performance liquid chromatography (HPLC) in absolute methanol solvent after conversion into a methyl ester. The yield of the product is about 70% to 95% and the purity is about 90% or more.

Na-Nsc-amino acid fluoride derivatives prepared by fluorination of Nsc-amino acids exhibit some differences in a nuclear magnetic resonance (NMR). Thus, the product containing fluoride group can be very readily analyzed by discovering the peak around 1840 cm''according to an infrared (IR) spectroscopy.

The storage and preservation are important to fluoride derivatives. Nsc-amino acid fluorides can be stored and preserved under nitrogen atmosphere or in a refrigerator for about one month without decomposition. It is regarded that such storage stability is far superior to that of the fluoride derivatives of other Na-protected amino acids, particularly Fmoc-amino acid-fluorides. In addition, in view of the stability in solvent, it can be identified that Nsc-amino acid fluorides can be retained in DMF for 24 hours or more.

Table 1. Definition of R, and R, in the compounds of formula (I) Number R1 R2 Amino acid Abbreviation I-1 H H glycine Nsc-Gly-F I-2 H isopropyl valine Nsc-Val-F I-3 H 2-methylpropyl leucine Nsc-Leu-F I-4 H tert-butoxybenzyl O-tert-butyl-serine Nsc-Ser(tBu)-F I-5 H benzyl phenylalanine Nsc-Phe-F I-6 H 2-(tert-butoxycarbonyl) glutamic acid γ-tert- Nsc-Glu(OtBu)-F ethyl butyl ester I-7 H 4-(tert-butoxycarbonyl) N#-tert-butoxycarbonyl Nsc-Lys(Boc)-F butyl lysine I-8 H 4-tert-butoxybenzyl O-tert-butyl lysine Nsc-Tyr(tBu)-F

The utility of Na-Nsc-amino acid fluorides thus prepared can be proved as follows. First, in actual synthesis Na-Nsc-amino acid fluorides can readily accomplish the synthesis of peptides, which are difficult to synthesize by means of Fmoc-protected amino acid fluorides. Examples of such peptides include Leu-enkephalin, A-VI-5, (3- amyloid peptide (16-20), etc. It could be observed that peptides thus synthesized exhibit more increased activity.

The protocol of such reactions is as follows. All of the coupling reactions were carried out in the presence of DMF and the deprotection was carried out in 1 % DBU-20% piperidine/DMF solvent. This is the standard protocol, in which the

condensation reaction is conducted for 40 minutes and the deprotection is conducted for 14 minutes (10 minutes/3 minutes/1 minute). PEG-PS resin was used as the solid phase support and the synthetic reactions were conducted following the manual for a synthesizer (Pioneer model). Finally, a suitable scavenger was added in the presence of trifluoroacetic acid (TFA) and then, the reaction mixture was stirred for about 2 hours to terminate the cleavage reaction.

Specific examples of the synthesis accomplished through the above reactions can be shown in the following.

EXAMPLE 1 Synthesis of Nsc-Val-F 374 mg (1 mmol) of Nsc-Val-OH was dissolved in 5 ml of dichloromethane (DCM), and 266 u. l (3 mmol) of cyanuric fluoride and 81 pl (1 mmol) of thoroughly dried pyridine were added thereto. The reaction mixture was then stirred under nitrogen atmosphere for 30 minutes.

Water-soluble white precipitate was filtered off and the filtrate was immersed in saline-cooled ice water and then filtered. The residue was absorbed into dried anhydrous magnesium sulfate (MgSO4) g to remove any retained moisture and then filtered. The filtrate was evaporated and dried. The organic layer was recrystallized from dichloromethane (DCM)-hexane solution to obtain the white solid (Yield : 82%).

The physical properties of Nsc-amino acid fluorides thus synthesized are summarized in the following Table 2.

Table 2. Physical properties of Nsc-amino acid fluorides Amino acid mp (°C) a [a] Db IR Punty Yield fluorides (cm-2)c Nsc-Gly-F 101. 2-103. 78-1855 95. 1 79. 2 Nsc-Val-F 75. 3-84. 8 +12. 2 (c 1. 0, DCM) 1843 93. 4 89. 1 Nsc-Phe-F 103. 5-105. 1 +33. 3 (c 1. 0, DCM) 1843 94. 1 84. 9 Nsc-Leu-F 63. 9-69. 4-11. 2 (c 1. 0, THF) 1844 92. 3 71. 6 Nsc-Tyr (tBu)-F 63. 2-65. 2 +30. 6 (c 2. 2, DCM) 1844 97. 5 95. 3 Nsc-Lys (Boc)-F 110. 3-118, 9 +8. 4 (c 1. 0, DCM) 1835 90. 1 95. 2 Nsc-Glu (OtBu)-F 96. 1-100. 3 +9. 2 (c 1. 0, DCM) 1843 92. 2 88. 7 Nsc-Ser (tBu)-F 100. 3-104. 9 +8. 3 (c 1. 0, DCM) 1851 98. 1 89. 1

Note) a measuring apparatus : BUCHI 531 model b JASCO DIP1000 model/25°C c JASCO FT/IR 300E model/KBr-Pellet d After conversion into methyl ester by treatment with anhydrous MeOH, identification by HPLC EXAMPLE 2 Synthesis of Nsc-Gly-F 332. 3 mg (1 mmol) of Nsc-Gly-OH was added to 50 ml of dry dichloromethane (DCM) and then stirred in suspension. 266 cl of cyanuric fluoride and thoroughly dried pyridine were added and the reaction mixture was then stirred for 3 hours under nitrogen. The reaction was terminated by addition of ice to the reaction solution and

the organic layer was extracted with dichloromethane (DCM), dried over anhydrous magnesium sulfate (MgS04), filtered and then concentrated. The concentrate was treated with dichloromethane (DCM)-diethyl ether to obtain the white solid (Yield : 79. 2%).

EXAMPLE 3 Synthesis of Nsc-Phe-F 422. 4 mg (1 mmol) of Nsc-Phe-OH was added to 50 ml of dry dichloromethane (DCM) and then stirred in suspension. 266 Ill of cyanuric fluoride and 81 pl of thoroughly dried pyridine were added and the reaction mixture was then stirred for 6 hours under nitrogen. The reaction solution was concentrated and then, ethyl acetate and ice were added to the residue. The organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate (MgSO4) and then concentrated. The concentrate was treated with dichloromethane (DCM) to obtain the white solid (Yield : 84. 9%).

EXAMPLE 4 Synthesis of Nsc-Leu-F 388. 4 mg (1 mmol) of Nsc-Leu-OH was added to 50 ml of dry dichloromethane (DCM) and then stirred in suspension. 266 u. l of cyanuric fluoride and 81 pl of thoroughly dried pyridine were added and the reaction mixture was then stirred for 6 hours under nitrogen. The reaction solution was concentrated and then, ethyl acetate and ice were added to the residue. The organic layer was extracted with ethyl acetate, dried over anhydrous magnesium sulfate (MgSO4) and then concentrated. The concentrate was treated with diethyl ether and petroleum ether to obtain the white solid (Yield : 70%).

EXAMPLE 5 Synthesis of Nsc-Tyr (tBu)-F 422. 4 mg (1 mmol) of Nsc-Tyr (tBu)-OH was added to 50 ml of dry dichloromethane (DCM) and then stirred in solution. 266 u. l of cyanuric fluoride and 81 RI of thoroughly dried pyridine were added and the reaction mixture was then stirred for 6 hours under nitrogen. The reaction was terminated by addition of ice to the reaction solution and the organic layer was extracted with dichloromethane (DCM).

The extract was dried over anhydrous magnesium sulfate (MgSO4), concentrated and then treated with diethyl ether to obtain the white solid (Yield : 95. 2%).

EXAMPLE 6 Synthesis of Nsc-Lys (Boc)-F 503. 5 mg (1 mmol) of Nsc-Lys (Boc)-OH was dissolved in 5 ml of dry dichloromethane (DCM). 266 Ill of cyanuric fluoride and 81 ul of pyridine were added thereto and the reaction mixture was then stirred for 30 minutes under nitrogen atmosphere. The white solid produced during the reaction was filtered off and ice water was introduced into the filtrate to separate only the dichloromethane (DCM) layer, which was then dried over magnesium sulfate (MgSO4) dried with dichloromethane (DCM), filtered and then evaporated. The residue was recrystallized from dichloromethane (DCM)-hexane solution to obtain the white solid (78%).

EXAMPLE 7 Synthesis of Nsc-Glu (OtBu)-F 460. 5 mg (1 mmol) of Nsc-Glu (OtBu)-OH was dissolved in 5 ml of dry

dichloromethane (DCM). 266 « of cyanuric fluoride and 81 ul of pyridine were added thereto and the reaction mixture was then stirred for 30 minutes under nitrogen atmosphere. The white solid produced during the reaction was filtered off and ice water was introduced into the filtrate to separate only the dichloromethane (DCM) layer, which was then dried over magnesium sulfate (MgSO4) dried with dichloromethane (DCM), filtered and then evaporated. The residue was recrystallized from dichloromethane (DCM)-hexane solution to obtain the white solid (81%).

EXAMPLE 8 Synthesis of Nsc-Ser (tBu)-F 418. 4 mg (1 mmol) of Nsc-Ser (tBu)-OH was dissolved in 5 ml of dry dichloromethane (DCM). 266 pl of cyanuric fluoride and 81 nl ofpyridine were added thereto and the reaction mixture was then stirred for 30 minutes under nitrogen atmosphere. The white solid produced during the reaction was filtered off and ice water was introduced into the filtrate to separate only the dichloromethane (DCM) layer, which was then dried over magnesium sulfate (MgSO4) dried with dichloromethane (DCM), filtered and then evaporated. The residue was recrystallized from dichloromethane (DCM)-hexane solution to obtain the white solid (84%).

EXAMPLE 9 Synthesis of Leu-enkephalin using Nsc-amino acid fluorides Sequence : Tyr-Gly-Gly-Phe-Leu Resin : Fmoc-Leu-Peg-PS (0. 2 mmol/g) used 100 mg Coupling condition : 2 excess amino acid fluoride without base

Reaction media : DMF (reaction volume 1 ml) Deprotection : 1% DBU-20% piperidine in DMF (5 min/1 min/1 min) TFA-cleavage : 95% TFA/2. 5% water/2. 5% phenol Fmoc-Leu-Peg-PS resin was introduced into a Ramps-kit reaction vessel, activated with 2 ml of dichloromethane (DCM) and then thoroughly washed with DMF.

1 ml of deprotection solvent was added and then Ramps-kit reaction vessel was well shaken for 5 minites. The reaction solution was then filtered and then 1 ml of deprotection solvent was added again. The reaction solution was shaken again for one minute and then filtered. 1 ml of deprotection solvent was added again and then, the reaction solution was shaken again for one minute and then filtered. The respective filtrates were separately preserved in order to observe the deprotection process.

After completion of the deprotection, resin was washed three times with DMF, three times with dichloromethane (DCM), three times with MeOH and then three times with DMF. 17 mg (0. 04 mmol) of Nsc-Phe-F was dissolved in 1 ml of DMF, introduced into the reaction vessel and then well shaken for 20 minutes. Then, the reaction mixture was washed three times with DMF, three times with dichloromethane (DCM), three times with MeOH and then three times with DMF. The deprotection step (De-Nsc) and condensation step were repeated two times in case of Nsc-Gly-F and one time in case of Nsc-Tyr (tBu)-F. After Nsc was finally removed, the reaction solution was well washed and then dried. 5 ml of TFA-cleavage solution was added to well dried resin and then, the mixture was allowed to stand for 2 hours, concentrated to remove THF and then treated with excess diethyl ether to obtain the white powder after filtration (Yield : 75%).

EXAMPLE 10

Synthesis of A-VI-5 peptide using Nsc-amino acid fluorides Sequence : H-Val-Glu-Ser-Ser-Lys-OH Resin : Fmoc-Lys (Boc)-PEG-PS Loading : 0. 18 mmol/g Amount : 200 mg Excess reagent : 5 times Base : 1 equivalent DIEA Coupling time : 20 minutes Deblocking time : 10 minutes (1% DBU / 20% piperidine / DMF) Amino acid fluorides as used Nsc-Val-F : 338 mg Nsc-Ser (tBu)-F : 756 mg Nsc-Glu (otBu)-F : 415 mg After completion of the synthesis, the final cleavage reaction was conducted using TFA and the reaction solution was filtyered. To the resulting solution was added cold anhydrous ether to obtain the white solid (72%).

EXAMPLE 11 Svnthesis of p-amyloid peptide using Nsc-amino acid fluorides

Sequence : H-Lys-Leu-Val-Phe-Phe-OH Resin : Fmoc-Phe-PEG-PS Loading : 0. 21 mmol/g Amount : 100 mg Excess reagent : 5 times Base : No base Coupling time : 40 minutes Deblocking time : 15 minutes (1% DBU / 20% piperidine / DMF) Amino acid fluorides as used Nsc-Val-F : 395 mg Nsc-Leu-F : 357 mg Nsc-Lys (Boc)-F : 531 mg After completion of the synthesis, the final cleavage reaction was conducted using TFA and the reaction solution was filtyered. To the resulting solution was added cold anhydrous ether to obtain the white solid (75%).